David Andrew Coates,Kevin Robert Fales,Jeffrey Allen Peterson,Jeffrey Michael Schkeryantz, II,Quanrong , Shen,Matthew John Valli,John Rowley Wetterau, II,Dariusz Stanislaw Wodka,Yanping Xu
申请号：
US16321575
公开号：
US20200031813A1
申请日:
2017.08.08
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention provides compounds of the formula: (A), pharmaceutically acceptable salts, pharmaceutical compositions thereof and methods of using these compounds, salts, or compositions to treat hyperphosphatemia, chronic kidney disease, and/or the cardiovascular disease associated with chronic kidney disease.
